| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.02 | 0.9 |